Theresa Hickman

949 total citations
9 papers, 149 citations indexed

About

Theresa Hickman is a scholar working on Genetics, Biotechnology and Molecular Biology. According to data from OpenAlex, Theresa Hickman has authored 9 papers receiving a total of 149 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Genetics, 6 papers in Biotechnology and 5 papers in Molecular Biology. Recurrent topics in Theresa Hickman's work include Virus-based gene therapy research (7 papers), Cancer Research and Treatments (6 papers) and Viral Infectious Diseases and Gene Expression in Insects (3 papers). Theresa Hickman is often cited by papers focused on Virus-based gene therapy research (7 papers), Cancer Research and Treatments (6 papers) and Viral Infectious Diseases and Gene Expression in Insects (3 papers). Theresa Hickman collaborates with scholars based in United States, South Korea and Canada. Theresa Hickman's co-authors include David H. Kirn, Caroline J. Breitbach, Chang Won Kim, Jeong Heo, Tae-Ho Hwang, Hyun Young Woo, Kelley A. Parato, Mi Kyung Kim, Sung Yong Oh and Theresa Falls and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Hepatology and Annals of Oncology.

In The Last Decade

Theresa Hickman

9 papers receiving 147 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Theresa Hickman United States 4 98 87 44 37 27 9 149
Chryssanthi Kournioti United States 4 148 1.5× 57 0.7× 54 1.2× 35 0.9× 12 0.4× 7 193
Elizabeth Appleton United Kingdom 4 93 0.9× 98 1.1× 51 1.2× 46 1.2× 19 0.7× 11 155
Zhiwen Wu Japan 5 171 1.7× 149 1.7× 100 2.3× 49 1.3× 46 1.7× 5 252
Tamar Plitt United States 4 90 0.9× 108 1.2× 51 1.2× 69 1.9× 9 0.3× 6 169
Samantha Turnbull United Kingdom 6 57 0.6× 91 1.0× 37 0.8× 18 0.5× 8 0.3× 9 127
Jay Naik United Kingdom 6 101 1.0× 108 1.2× 54 1.2× 26 0.7× 20 0.7× 13 181
Katrina Pirlo United Kingdom 8 106 1.1× 83 1.0× 117 2.7× 22 0.6× 15 0.6× 10 167
Ekaterina Bayurova Russia 7 22 0.2× 41 0.5× 85 1.9× 34 0.9× 3 0.1× 19 177
Kyle Potts Canada 5 60 0.6× 48 0.6× 42 1.0× 18 0.5× 24 0.9× 13 114
Stefanie Sawall Germany 3 90 0.9× 43 0.5× 60 1.4× 17 0.5× 11 0.4× 3 142

Countries citing papers authored by Theresa Hickman

Since Specialization
Citations

This map shows the geographic impact of Theresa Hickman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Theresa Hickman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Theresa Hickman more than expected).

Fields of papers citing papers by Theresa Hickman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Theresa Hickman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Theresa Hickman. The network helps show where Theresa Hickman may publish in the future.

Co-authorship network of co-authors of Theresa Hickman

This figure shows the co-authorship network connecting the top 25 collaborators of Theresa Hickman. A scholar is included among the top collaborators of Theresa Hickman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Theresa Hickman. Theresa Hickman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Ciombor, Kristen K., Jennifer G. Whisenant, Gregory D. Ayers, et al.. (2023). P-187 Targeting glutamine metabolism and EGFR in RAS wildtype colorectal cancer. Annals of Oncology. 34. S82–S82. 1 indexed citations
2.
Lencioni, Riccardo, Caroline J. Breitbach, John M. Burke, et al.. (2015). 2219 Intratumoral injection of the oncolytic immunotherapeutic Pexa-Vec (JX-594) in liver tumors and hepatocellular carcinoma: Recommendations for clinical practice. European Journal of Cancer. 51. S405–S406. 1 indexed citations
4.
Heo, Jeong, Caroline J. Breitbach, Mong Cho, et al.. (2013). Phase II trial of Pexa-Vec (pexastimogene devacirepvec; JX-594), an oncolytic and immunotherapeutic vaccinia virus, followed by sorafenib in patients with advanced hepatocellular carcinoma (HCC).. Journal of Clinical Oncology. 31(15_suppl). 4122–4122. 9 indexed citations
5.
Heo, Jeong, Caroline J. Breitbach, Mong Cho, et al.. (2012). A phase II trial of JX-594, a targeted multimechanistic oncolytic vaccinia virus, followed by sorafenib in patients with advanced hepatocellular carcinoma (HCC).. Journal of Clinical Oncology. 30(15_suppl). e14566–e14566. 3 indexed citations
6.
7.
Heo, Jeong, Caroline J. Breitbach, Anne Moon, et al.. (2011). Sequential Therapy With JX-594, A Targeted Oncolytic Poxvirus, Followed by Sorafenib in Hepatocellular Carcinoma: Preclinical and Clinical Demonstration of Combination Efficacy. Molecular Therapy. 19(6). 1170–1179. 117 indexed citations
8.
Lim, Ho-Yeong, Leyo Ruo, Mark Bloomston, et al.. (2010). 124 RANDOMIZED PHASE II CLINICAL TRIAL OF INTRATUMORAL INJECTION OF JX-594, A TARGETED MULTI-MECHANISTIC ONCOLYTIC POXVIRUS, IN PATIENTS WITH HEPATOCELLULAR CARCINOMA. Journal of Hepatology. 52. S55–S55. 3 indexed citations
9.
Stohs, Sidney J., et al.. (1987). Erythrocyte membrane microviscosity and phospholipid composition in lead workers.. Occupational and Environmental Medicine. 44(12). 841–844. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026